Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, B. | - |
dc.contributor.author | Kim, J. | - |
dc.contributor.author | Seo, M-R. | - |
dc.contributor.author | Wie, S-H. | - |
dc.contributor.author | Cho, Y. K. | - |
dc.contributor.author | Lim, S-K. | - |
dc.contributor.author | Lee, J. S. | - |
dc.contributor.author | Kwon, K. T. | - |
dc.contributor.author | Lee, H. | - |
dc.contributor.author | Cheong, H. J. | - |
dc.contributor.author | Park, D. W. | - |
dc.contributor.author | Ryu, S. Y. | - |
dc.contributor.author | Chung, M-H. | - |
dc.contributor.author | Ki, M. | - |
dc.contributor.author | Pai, H. | - |
dc.date.accessioned | 2021-09-06T00:46:52Z | - |
dc.date.available | 2021-09-06T00:46:52Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2013-06 | - |
dc.identifier.issn | 0300-8126 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/103011 | - |
dc.description.abstract | The aim of this study was to determine the risk factors and clinical characteristics of community-acquired acute pyelonephritis (CA-APN) caused by extended-spectrum beta-lactamase (ESBL)-producing organisms. From March 2010 to February 2011, patients with CA-APN were recruited in 11 hospitals in South Korea. Clinical and microbiological data were collected prospectively, and the ESBLs and multilocus sequence types of the ESBL-producing Escherichia coli were characterized. Comparison between CA-APN caused by ESBL-producing Enterobacteriaceae and those by non-ESBL-producing organisms was performed. A total of 566 patients were recruited. Enterobacteriaceae were detected in 526 patients. Forty-six isolates (46/526, 8.7 %) were positive for ESBLs. Clinical and microbiological failure did not differ between the two groups, despite there being fewer patients with ESBL-positive isolates provided with appropriate antibiotics initially (19.6 vs. 93.8 %, p < 0.001). However, the duration of hospitalization was longer in the ESBL group (10.5 vs. 7.0 days, p = 0.012). In a logistic regression model, Charlson score a parts per thousand yen1 point [odds ratio (OR) 3.4, 95 % confidence interval (CI) 1.6-7.0, p = 0.001], antibiotics usage during the previous year (OR 3.1, 95 % CI 1.4-7.2, p = 0.008), and urinary catheterization during the previous month (OR 4.4, 95 % CI 1.1-17.6, p = 0.035) were associated with the risks of CA-APN by ESBL producers. CTX-M-15 (48 %) and CTX-M-14 (38 %) were the most common ESBLs. ST131 was the most common clone (7/24, 29.1 %), which was more frequently resistant to cefepime, fosfomycin, and temocillin. The risk factors for CA-APN by ESBL producers were Charlson score a parts per thousand yen1 point, antibiotics usage during the previous year, and urinary catheterization during the previous month. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER HEIDELBERG | - |
dc.subject | URINARY-TRACT-INFECTIONS | - |
dc.subject | SPECTRUM BETA-LACTAMASES | - |
dc.subject | KLEBSIELLA-PNEUMONIAE BACTEREMIA | - |
dc.subject | RESISTANT ESCHERICHIA-COLI | - |
dc.subject | BLOOD-STREAM INFECTIONS | - |
dc.subject | RISK-FACTORS | - |
dc.subject | MULTIPLEX PCR | - |
dc.subject | ENTEROBACTERIACEAE | - |
dc.subject | EPIDEMIOLOGY | - |
dc.title | Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Cheong, H. J. | - |
dc.identifier.doi | 10.1007/s15010-013-0441-z | - |
dc.identifier.scopusid | 2-s2.0-84878866083 | - |
dc.identifier.wosid | 000319887000001 | - |
dc.identifier.bibliographicCitation | INFECTION, v.41, no.3, pp.603 - 612 | - |
dc.relation.isPartOf | INFECTION | - |
dc.citation.title | INFECTION | - |
dc.citation.volume | 41 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 603 | - |
dc.citation.endPage | 612 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | URINARY-TRACT-INFECTIONS | - |
dc.subject.keywordPlus | SPECTRUM BETA-LACTAMASES | - |
dc.subject.keywordPlus | KLEBSIELLA-PNEUMONIAE BACTEREMIA | - |
dc.subject.keywordPlus | RESISTANT ESCHERICHIA-COLI | - |
dc.subject.keywordPlus | BLOOD-STREAM INFECTIONS | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | MULTIPLEX PCR | - |
dc.subject.keywordPlus | ENTEROBACTERIACEAE | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordAuthor | Extended-spectrum beta-lactamase | - |
dc.subject.keywordAuthor | Urinary tract infection | - |
dc.subject.keywordAuthor | Community acquired | - |
dc.subject.keywordAuthor | Risk factor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.